Latest papers

Lateralized ictal dystonia of upper and lower limbs in patients with temporal lobe epilepsy.

Imaging of active multiple sclerosis plaques: efficiency of contrast-enhanced magnetization transfer subtraction technique.

Histopathology of lupus nephritis.

A novel approach to dementia: high-resolution 1H MRI of the human hippocampus performed at 21.1 T.

Refractory gastric ulcer with abundant IgG4-positive plasma cell infiltration: a case report.

Postsplenectomy sclerosing extramedullary hematopoietic tumor with unexpected good clinical evolution: morphologic, immunohistochemical, and molecular analysis of one case and review of the literature.

Intraoral sclerosing perineurioma: a case report and review of the literature.

Sclerosing polycystic adenosis of the parotid gland: report of one case diagnosed by fine-needle cytology with in situ malignant transformation.

Hippocampal cell loss and propagation of abnormal discharges accompanied with the expression of tonic convulsion in the spontaneously epileptic rat.

Now you see it, now you don't: morphologic variability is a confounder in chronic rejection/graft sclerosis.

Estimation of age from sclerotic glomeruli.

A salivary gland adenocarcinoma mimicking a microcystic adnexal carcinoma.

Sclerosing encapsulating peritonitis: complication of laparoscopic cholecystectomy.

A large sclerosing stromal tumour of the ovary presenting with irregular uterine bleeding: first case report from the UK.

Sclerosing mesenteritis involving the pancreas: a mimicker of pancreatic cancer.

Effects of glutamine supplementation on kidney of diabetic rat.

Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent.

Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent.

Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent.

Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent.